These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30458204)

  • 21. Antibody-defined epitopes on HLA-DQ alleles reacting with antibodies induced during pregnancy and the design of a DQ eplet map.
    Duquesnoy RJ; Hönger G; Hösli I; Marrari M; Schaub S
    Hum Immunol; 2016 Oct; 77(10):824-831. PubMed ID: 27374949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of molecular matching in transplantation requires further characterization of both immunogenicity and antigenicity of individual HLA epitopes.
    Bezstarosti S; Kramer CSM; Claas FHJ; de Fijter JW; Reinders MEJ; Heidt S
    Hum Immunol; 2022 Mar; 83(3):256-263. PubMed ID: 34963506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining the immunogenicity and antigenicity of HLA epitopes is crucial for optimal epitope matching in clinical renal transplantation.
    Kramer CSM; Roelen DL; Heidt S; Claas FHJ
    HLA; 2017 Jul; 90(1):5-16. PubMed ID: 28378521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards the identification of the relative immunogenicity of individual HLA antibody epitopes.
    Kramer C; Heidt S; Claas FHJ
    Hum Immunol; 2019 Apr; 80(4):218-220. PubMed ID: 30735757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA matching at the epitope level: the way to go.
    Duquesnoy RJ
    Clin Transpl; 2013; ():441-51. PubMed ID: 25095540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-EPI: A new EPIsode in exploring donor/recipient epitopic compatibilities.
    Geffard E; Boussamet L; Walencik A; Delbos F; Limou S; Gourraud PA; Vince N
    HLA; 2022 Feb; 99(2):79-92. PubMed ID: 34862850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human monoclonal antibody reactivity with human leukocyte antigen class I epitopes defined by pairs of mismatched eplets and self-eplets.
    Marrari M; Mostecki J; Mulder A; Claas F; Balazs I; Duquesnoy RJ
    Transplantation; 2010 Dec; 90(12):1468-72. PubMed ID: 21063243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epitope analysis of HLA-DQ antigens: what does the antibody see?
    Tambur AR; Rosati J; Roitberg S; Glotz D; Friedewald JJ; Leventhal JR
    Transplantation; 2014 Jul; 98(2):157-66. PubMed ID: 25003284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are We Ready for Epitope-Based HLA Matching in Clinical Organ Transplantation?
    Duquesnoy RJ
    Transplantation; 2017 Aug; 101(8):1755-1765. PubMed ID: 28207632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A structurally based approach to determine HLA compatibility at the humoral immune level.
    Duquesnoy RJ
    Hum Immunol; 2006 Nov; 67(11):847-62. PubMed ID: 17145365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA graph, a free and ready-to-use bioinformatics tool to explore anti-HLA eplets reactivity pattern.
    Usureau C; Jacob V; Dubois V; Masson D; Jollet I; Desoutter J; Taupin JL; Guillaume N
    HLA; 2022 Sep; 100(3):244-253. PubMed ID: 35672253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-C antibodies are associated with irreversible rejection in kidney transplantation: Shared molecular eplets characterization.
    Bosch A; Llorente S; Eguia J; Mrowiec A; Boix F; López-Hernández R; Campillo JA; Salgado G; Moya-Quiles MR; Minguela A; Jimeno L; Alvarez-López MR; Muro M
    Hum Immunol; 2014 Apr; 75(4):338-41. PubMed ID: 24486575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.
    Duquesnoy RJ; Askar M
    Hum Immunol; 2007 Jan; 68(1):12-25. PubMed ID: 17207708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.
    Duquesnoy RJ; Awadalla Y; Lomago J; Jelinek L; Howe J; Zern D; Hunter B; Martell J; Girnita A; Zeevi A
    Transpl Immunol; 2008 Feb; 18(4):352-60. PubMed ID: 18158123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical evaluation of a possible role of HLA epitope matching in kidney transplantation.
    Kumru Sahin G; Unterrainer C; Süsal C
    Transplant Rev (Orlando); 2020 Apr; 34(2):100533. PubMed ID: 32007300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural aspects of human leukocyte antigen class I epitopes detected by human monoclonal antibodies.
    Duquesnoy RJ; Marrari M; Mulder A; Claas FH; Mostecki J; Balazs I
    Hum Immunol; 2012 Mar; 73(3):267-77. PubMed ID: 22227099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of amino acid mismatch in the UNOS dataset.
    Sasaki N; El-Awar N; Idica A
    Clin Transpl; 2011; ():299-309. PubMed ID: 22755423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structurally based epitope analysis of major histocompatibility complex class I-related chain A (MICA) antibody specificity patterns.
    Duquesnoy RJ; Mostecki J; Hariharan J; Balazs I
    Hum Immunol; 2008 Dec; 69(12):826-32. PubMed ID: 18957310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using the mimetic epitope concept to find a possible way to widen the graft-survival difference between matched and mismatched renal transplants.
    Sasaki N; Idica A; Hall B; Terasaki PI
    Clin Transpl; 2008; ():241-52. PubMed ID: 19711515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of antibodies against HLA-C epitopes in patients with rejected kidney transplants.
    Duquesnoy RJ; Marrari M
    Transpl Immunol; 2011 Apr; 24(3):164-71. PubMed ID: 21185937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.